JP2020511159A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020511159A5 JP2020511159A5 JP2019570603A JP2019570603A JP2020511159A5 JP 2020511159 A5 JP2020511159 A5 JP 2020511159A5 JP 2019570603 A JP2019570603 A JP 2019570603A JP 2019570603 A JP2019570603 A JP 2019570603A JP 2020511159 A5 JP2020511159 A5 JP 2020511159A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- represented
- il17a
- pharmaceutical composition
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2017/076278 WO2018161340A1 (en) | 2017-03-10 | 2017-03-10 | Monoclonal antibody against both il-17a and il-17f and use of the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020511159A JP2020511159A (ja) | 2020-04-16 |
| JP2020511159A5 true JP2020511159A5 (https=) | 2020-05-28 |
| JP6876156B2 JP6876156B2 (ja) | 2021-05-26 |
Family
ID=63448085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019570603A Active JP6876156B2 (ja) | 2017-03-10 | 2017-03-10 | Ｉｌ−１７ａ及びｉｌ−１７ｆに反応するモノクローナル抗体、及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10858427B2 (https=) |
| EP (1) | EP3592771A4 (https=) |
| JP (1) | JP6876156B2 (https=) |
| KR (1) | KR102321861B1 (https=) |
| CN (1) | CN110582512B (https=) |
| AU (1) | AU2017402210B2 (https=) |
| WO (1) | WO2018161340A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110003329B (zh) * | 2019-04-12 | 2022-09-27 | 深圳普瑞金生物药业股份有限公司 | 多肽、il17a/f单域抗体、核苷酸序列及试剂盒 |
| US11827709B2 (en) * | 2019-12-05 | 2023-11-28 | Seagen Inc. | Anti-AVB6 antibodies and antibody-drug conjugates |
| CN112915201B (zh) * | 2019-12-06 | 2023-06-27 | 珠海市丽珠单抗生物技术有限公司 | 包含抗il-17抗体的液体制剂 |
| CN119301153A (zh) * | 2022-06-29 | 2025-01-10 | 上海齐鲁制药研究中心有限公司 | 结合il-17a和il-17f的抗体分子及其应用 |
| CN116063493B (zh) * | 2022-07-22 | 2023-09-01 | 贵州省赛尔生物科技有限公司 | 包含抗体和间充质干细胞外泌体的药物组合物及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070160576A1 (en) | 2001-06-05 | 2007-07-12 | Genentech, Inc. | IL-17A/F heterologous polypeptides and therapeutic uses thereof |
| EP1963368B3 (en) * | 2005-12-13 | 2020-06-10 | Eli Lilly And Company | Anti-il-17 antibodies |
| EP1996622A2 (en) * | 2006-03-10 | 2008-12-03 | Zymogenetics, Inc. | Antibodies that bind both il-17a and il-17f and methods of using the same |
| JP5116842B2 (ja) | 2007-04-27 | 2013-01-09 | ザイモジェネティクス， インコーポレイテッド | ＩＬ−１７ＡおよびＩｌ−１７Ｆの両方に結合する抗体ならびにそれを使用する方法 |
| GB0807413D0 (en) * | 2008-04-23 | 2008-05-28 | Ucb Pharma Sa | Biological products |
| RU2474588C2 (ru) * | 2008-05-05 | 2013-02-10 | Новиммун Са | Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения |
| MA33248B1 (fr) | 2009-04-01 | 2012-05-02 | Genentech Inc | Traitement de troubles résistant à l'insuline |
| CN102458437B (zh) | 2009-05-05 | 2015-06-10 | 诺维莫尼公司 | 抗il-17f抗体及其使用方法 |
| ME02734B (me) * | 2011-01-14 | 2017-10-20 | Ucb Biopharma Sprl | Antitelo koje vezuje il-17a i il-17f |
| US8945553B2 (en) | 2012-05-22 | 2015-02-03 | Bristol-Myers Squibb Company | Bispecific antibodies to IL-23 and IL-17A/F |
| LT2953969T (lt) * | 2013-02-08 | 2019-12-10 | Novartis Ag | Anti-il-17a antikūnai ir jų panaudojimas autoimuninių ir uždegiminių ligų gydymui |
| WO2014161570A1 (en) * | 2013-04-03 | 2014-10-09 | Roche Glycart Ag | Antibodies against human il17 and uses thereof |
| EP3027649B1 (en) * | 2013-08-01 | 2020-04-01 | F.Hoffmann-La Roche Ag | Tnfa-il-17 bispecific antibodies |
| CN106336459B (zh) * | 2015-07-13 | 2020-12-08 | 三生国健药业（上海）股份有限公司 | 抗人白细胞介素-17a单克隆抗体、其制备方法和应用 |
-
2017
- 2017-03-10 US US16/491,297 patent/US10858427B2/en active Active
- 2017-03-10 JP JP2019570603A patent/JP6876156B2/ja active Active
- 2017-03-10 EP EP17899842.3A patent/EP3592771A4/en active Pending
- 2017-03-10 KR KR1020197029557A patent/KR102321861B1/ko active Active
- 2017-03-10 WO PCT/CN2017/076278 patent/WO2018161340A1/en not_active Ceased
- 2017-03-10 AU AU2017402210A patent/AU2017402210B2/en active Active
- 2017-03-10 CN CN201780087699.1A patent/CN110582512B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020511159A5 (https=) | ||
| RU2458071C2 (ru) | Антитела-нейтрализаторы гранулоцитарно-макрофагального колониестимулирующего фактора человека | |
| JP2017079785A5 (https=) | ||
| FI3592384T3 (fi) | Vasta-aineita, jotka spesifisesti sitoutuvat ihmisen IL-1R7:ään | |
| HRP20201633T1 (hr) | Protutijela koja se vežu na il-23 | |
| HRP20191608T1 (hr) | Proteini s ponavljajućim dipeptidom kao terapeutsko ciljno mjesto kod neurodegenerativnih bolesti s ekspanzijom ponavljajućeg heksanukleotida | |
| JP2020018311A5 (https=) | ||
| RU2011116927A (ru) | Антитела против интерлейкина 17 (ил-17) человека и их применение | |
| JP2017163973A5 (https=) | ||
| PE20181089A1 (es) | Anticuerpos anti-cd19 humano con alta afinidad | |
| JP2017184723A5 (https=) | ||
| HRP20191334T1 (hr) | Anti-fcrn antitijela | |
| JP2019054802A5 (https=) | ||
| JP2012501669A5 (https=) | ||
| HRP20180516T1 (hr) | Humanizirana protutijela specifična za protofibrilni oblik amiloidnog-beta peptida | |
| RU2019118359A (ru) | Антитело к cd73 человека | |
| JP2018121657A5 (https=) | ||
| JP2014516945A5 (https=) | ||
| JP2019522961A5 (https=) | ||
| JP2012100667A5 (https=) | ||
| RU2011135422A (ru) | Человеческие анти-il-6 антитела с пролонгированным периодом выведения in vivo и их применение при лечении онкологических, аутоиммунных заболеваний и воспалительных заболеваний | |
| RU2015144026A (ru) | Антитела против cd25 и их применения | |
| JP2010500005A5 (https=) | ||
| JP2014530611A5 (https=) | ||
| JP2011518857A5 (https=) |